Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,430 public trials 1,038 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia

NCT03035422

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations: Service d'hématologie Clinique Hôpital Saint Antoine Paris, France

View Trial Details

Completed

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

NCT02582879

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: Clearview Cancer Institute Huntsville, Alabama, United States

Northwest Alabama Cancer Center, PC Muscle Shoals, Alabama, United States

Arizona Oncology Associates, PC - HAL Glendale, Arizona, United States

Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States

View all 192 locations

View Trial Details

Completed

Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline.

NCT02546674

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Novartis Investigative Site Mannheim, Baden-Wurttemberg, Germany

Novartis Investigative Site Herne, North Rhine-Westphalia, Germany

Novartis Investigative Site Lübeck, Schleswig-Holstein, Germany

Novartis Investigative Site Aschaffenburg, Germany

View all 70 locations

View Trial Details

Completed

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

NCT01834248

Conditions: Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

NCT01827579

Conditions: Haematological Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: University College London Hospital London, United Kingdom

Manchester Royal Infirmary Manchester, United Kingdom

View Trial Details

Completed

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

NCT01903733

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Orlando Health, Inc Orlando, Florida, United States

Emory University Hospital Atlanta, Georgia, United States

The Emory Clinic Atlanta, Georgia, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

View all 91 locations

View Trial Details

Completed

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

NCT01005277

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Promyelocytic Leukemia With PML-RARA, +21 more
Locations: Childrens Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Prophylactic Application of Donor-derived TCM After Allogeneic HSCT

NCT02758223

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University Hospital Wuerzburg - Department of Medicine II Würzburg, Germany

View Trial Details

Completed

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT03023046

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML

NCT05456048

Conditions: Chromosome Aberrations, Cytogenetic Abnormality, Disease Attributes, +13 more
Locations: Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Leukemia

Leukemia trial results

Related conditions